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ABSTRACT
In this study, we describe a method of simultaneous
conditional gene silencing of up to four genes in
Escherichia coli by using antisense RNAs. We used
antisense RNAs with paired termini, which carried
flanking inverted repeats to create paired double-
stranded RNA termini; these RNAs have been
proven to have high silencing efficacy. To express
antisense RNAs, we constructed four IPTG-
inducible vectors carrying different but compatible
replication origins. When the lacZ antisense RNA
was expressed using these vectors, lacZ expression
was successfully silenced by all the vectors, but the
expression level of the antisense RNA and silencing
efficacy differed depending on the used vectors.
All the vectors were co-transformable; the antisense
RNAs against lacZ, ackA, pta and pepN were co-
expressed, and silencing of all the target genes
was confirmed. Furthermore, when antisense
RNAs were targeted to the mutator genes mutS,
mutD (dnaQ) and ndk, which are involved in DNA
replication or DNA mismatch repair, spontaneous
mutation frequencies increased over 2000-fold.
The resulting mutator strain is useful for random
mutagenesis of plasmids. The method provides a
robust tool for investigating functional relationships
between multiple genes or altering cell phenotypes
for biotechnological and industrial applications.
INTRODUCTION
Robust gene disruption and silencing methods are
required to characterize genes with unknown functions
or to engineer cells so that can express desired traits.
Disruption of a particular gene on a chromosome is a
suitable technique for ensuring the complete absence of
its function; however, this is possible with a limited set
of species and strains and is particularly problematic
when the gene is crucial for growth. On the other hand,
gene silencing is applicable even when the targeted genes
are essential for growth; moreover, conditional or revers-
ible gene silencing can be achieved easily. Antisense
RNA- and RNA interference (RNAi)-mediated gene silen-
cing are popular techniques used in eukaryotes; however,
RNAi mechanism is absent in bacteria, and hence, single-
stranded antisense RNAs (asRNAs) expressed from
expression vectors are frequently used for gene silencing
(1). The expressed asRNAs are typically designed to hybri-
dize the sequences ﬂanking the ribosome-binding site
(RBS) and the start codon of the target mRNAs. They
prevent ribosomes from recognizing the RBS, and thus
inhibit translation (2–4).
There are many examples of the application of
expressed asRNAs in diverse bacteria (4–8). For example,
asRNA expression library screens in Staphylococcus
aureus have revealed putative new essential genes and
growth inhibitors (5), and in the acetone-producing
bacterium Clostridium acetobutylicum, the acetone fer-
mentation pathway has been investigated by the silencing
of individual genes (9). However, there are also many
reports that state that low silencing eﬃcacy hampers phe-
notypic or molecular analysis, particularly in Escherichia
coli (1,10).
To overcome the low silencing eﬃcacy in E. coli,w e
recently developed a new IPTG-inducible expression
vector that expresses asRNAs with paired termini (PT),
wherein ﬂanking inverted repeats create paired double-
stranded RNA termini (Figure 1) (4). The PTasRNA
has a much higher silencing eﬃcacy than conventional
asRNAs because of better RNA stability, which increases
RNA abundance in cells. In fact, the PTasRNA against
the fabI gene, a gene essential for growth, inhibited cell
growth, while a conventional asRNA did not (4).
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vector was constructed; however, in theory, multiple
asRNAs can be expressed simultaneously in cells to
target multiple genes. In this study, we constructed four
PTasRNA expression vectors for E. coli. All these vectors
were IPTG-inducible, compatible and co-transformable.
Therefore, up to four genes could be silenced in parallel.
We demonstrated parallel silencing of a functionally unre-
lated gene set (lacZ, ackA, pta and pepN) and a related
gene set (mutS, mutD and ndk) and obtained expected
phenotypes. Silencing of the latter gene set resulted in
the generation of a mutator strain of E. coli that was
useful for random mutagenesis. Multiple gene silencing
mechanism is useful for investigating gene function and
gene interactions or for cell engineering.
MATERIALS AND METHODS
E. coli strains, plasmids and general techniques
The E. coli MG1655 strain was used as a host for expres-
sing PTasRNAs throughout the study. The DH5a strain
was used for only plasmid preparation. Both the strains
were always cultured in Luria Broth (LB; 1% bacto
tryptone, 0.5% bacto-yeast extract and 1% NaCl) in the
presence or absence of appropriate antibiotics at 378C.
The antibiotics used to select transformants were apramy-
cin (35mgm l
 1), chloramphenicol (24mgm l
 1), kanamy-
cin (15mgm l
 1) and ampicillin (50mgm l
 1). The plasmids
used in this study are listed in Table 1. Transformation
was carried out by the standard chemical method, and co-
transformation with multiple plasmids was carried out by
introducing two or more plasmids simultaneously. Cell
density was measured at 600nm in 200ml of the cultures
in a 96-well plate (Nalge Nunc International, Denmark;
product no. 269620) by using the Saﬁre microplate reader
(Tecan, Switzerland) and the LS-PLATEmanager 2004
data analysis program (Wako Pure Chemicals Co.,
Japan). PCR was performed using Pfu turbo polymerase
(Stratagene, La Jolla, CA) or KOD-plus polymerase
(Toyobo, Japan). When phosphate groups were required
at the 50-end of the PCR fragments for subsequent liga-
tion, T4 polynucleotide kinase (Toyobo) was used to
phosphorylate the oligonucleotides.
Construction of plasmids
The oligonucleotides that were used to amplify asRNA
sequences from the genomic DNA of the MG1655 strain
by PCR are shown in Table 2. All the PCR fragments were
digested with NcoI and XhoI and cloned into the NcoI-
XhoI moiety of the plasmids pHN1009, pHN678,
pHN1242, pHN1257 and/or pHN1270 (Figure 1 and
Table 1, and see below for the construction procedure).
To amplify the ColE1 and ampicillin-resistance gene
sequences, PCR was performed using the primers (TTT
GCTAGCTCTTTTGTTTATTTTTCTAAATACATTC
and AAAGGTACCATTATGCATGCCGCTTCGCCTT
CGCGC) and pBAD/HisA (Invitrogen Corp., Carlsbad,
CA) as a template. The ampliﬁed fragment was digested
with NheI and KpnI and ligated to the fragment contain-
ing the lacI
q and IPTG-inducible promoter sequences.
The latter fragment was obtained by performing PCR
using the primers (TTTGCTAGCAGAAGCATTGGTG
CACCGTGCAG and AAAGGTACCGTGGAGGTAA
TAATTGACGATATGA) and pHN678 (4) as a template,
followed by digestion with NheI and KpnI. The resulting
plasmid was named as pHN1009.
The pSC101 replication origin and apramycin-
resistance gene were ampliﬁed by PCR by using a
primer set (TTCATGCATTGACAGTAAGACGGGTA
AGCC and TAAGCTAGCTATGGACAGTTTTCCCT
TTGATATGTA) and pMW118 (Nippon Gene, Japan)
as a template, and by using a primer set (TAGGCTAG
CGATCCATGCCGTATTTGCAGCAGTG and TTTA
TGCATTGGTACCAAACGGCATTGAGCGTCAGCA
TATCATC) and pUC57-aac [custom-synthesized by
Genscript Corp. (Piscataway, NJ) on the basis of a
DNA sequence with a GenBank accession number
X01385] as a template, respectively. Both the PCR frag-
ments were digested with NsiI and NheI and ligated,
thereby yielding pHN1104. To remove the unwanted
SpeI and XhoI sites in pHN1104, PCR-based site-directed
mutagenesis was performed, and the sequences of both the
sites were modiﬁed from ACTAGT and CTCGAG to TC
TAGT and CTCGAA, respectively. The mutagenized
plasmid was named as pHN1114. A 1.9-kb fragment was
excised from pHN1009 by digestion with KpnI and NheI
and cloned into the KpnI-NsiI moiety of pHN1114 (NheI
and NsiI sites were blunted using T4 DNA polymerase
prior to ligation), thereby yielding pHN1237. A 1.4-kb
fragment carrying the kanamycin-resistance gene was
excised from pHN267 (11) by digestion with KpnI and
SpeI and was inserted into the KpnI-NheI moiety of
pHN1237, thereby yielding pHN1242. The copy-number
mutant of pHN1242 was generated by inverse PCR using
50-phosphorylated primers (AAGGCTTTAAGATTTTC
CAGTGGAC and TAACCAAAGGATTCCTGATTTC
CA) and named as pHN1257.
In order to amplify the RK2 origin sequence, PCR was
performed using two 50-phosphorylated primers (TCTCG
CTAGCTTTCTTCAGGGCCGACAATC and AGGCC
TCCGGGAGGGTTCGAGAAGGGG) and pCF430
[National BioResource Project (NIG, Japan); E. coli]a s
a template. A fragment containing the lacI
q, IPTG-indu-
cible promoter and apramycin-resistance gene was PCR-
ampliﬁed using two primers (TAGGCTAGCGATCCAT
GCCGTATTTGCAGCAGTG and TGCTAACTTACA
TTAATTGCGTTGC) and pHN1237 as a template.
These PCR fragments were ligated, thereby yielding
pHN1270.
Protein assays
For expressing the lacZ, ackA, pta and pepN PTasRNAs
and measuring their protein activities, transformants with
PTasRNA expression vector(s) were pre-grown overnight
in the absence of IPTG, diluted 1:400 with fresh media
containing 1mM IPTG, and cultured from mid- to late-
logarithmic phase. Cells were disrupted in phosphate-
buﬀered saline (0.14M NaCl, 2.7mM KCl, 10.1mM
Na2HPO4 and 1.8mM KH2PO4) using glass beads and a
Multi-beads shocker (Yasui Kikai, Japan) at 48C, and the
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for 15min at 48C. The total protein concentration
was determined using the Bio-Rad Bradford assay kit
(Bio-Rad, Hercules, CA).
The LacZ activity was measured in a microplate well
(Nalge Nunc International; product no. 269620) at room
temperature. The reaction mixture (180ml per well) was
composed of 0.14M NaCl, 2.7mM KCl, 10.1mM
Na2HPO4, 1.8mM KH2PO4, 1mM MgSO4,5 0 m M
2-mercaptoethanol, 0.4mg ml
 1 o-nitrophenyl-b-galacto-
side and cell extract. The absorbance was read at 420nm/
min using the Saﬁre reader, and the slope was used to
calculate the speciﬁc activity (mg protein
 1min
 1).
For the AckA assay, each reaction mixture (180ml) was
prepared in a UV-transparent microplate well (Costar,
NY; product no. 3635) that contained 200mM Tris–HCl
(pH 7.3), 200mM potassium acetate, 1.5mM ATP, 2mM
MgCl2, 6.4mM phospho(enol)pyruvate, 0.8mM NADH,
2mM dithiothreitol, 3.9 U pyruvate kinase, 9.5 U lactic
dehydrogenase and cell extract (typically, 0.8mg protein)
at room temperature. The NADH absorbance was read at
340nm/min using the Saﬁre reader, and the slope of the
conversion curve was used to calculate the speciﬁc activity
(mg protein
 1min
 1). The Pta activity was measured as
was done in the AckA assay by using a reaction mixture
(180ml) containing 200mM Tris–HCl (pH 8.0), 5mM
MgCl2, 15mM malic acid, 10mM NAD
+, 3.8mM CoA,
20mM acetyl-phosphate (lithium-potassium salt), 2.5 U
citrate synthase, 64 U malate dehydrogenase and cell
extract (typically, 4mg protein).
For the PepN assay, each reaction mixture (50ml) was
prepared in a black microplate well (Costar; product no.
3915) and contained 0.5mM ﬂuorogenic suc-LLVY-AMC
substrate (Bachem, Germany) and cell extract (typically,
50mg protein) at room temperature. Fluorescence was
read per minute using the Saﬁre reader, and the slope of
the ﬂuorescence intensity was used to calculate the speciﬁc
activity (mg protein
 1min
 1). The settings were as fol-
lows: excitation, 380nm; emission, 460nm; excitation
and emission bandwidths, 12nm; gain, 177; number of
ﬂashes, 10; Z-position 11019mm and integration time,
500ms.
Estimation of the plasmid copy number
The plasmid copy number per cell was estimated by
the agarose gel staining method (12), with modiﬁcations.
Each plasmid was digested with EcoRV and XhoI to yield
two bands and subjected to agarose gel electrophoresis.
Three diﬀerent volumes of each plasmid were loaded
onto the gel, thus ensuring linearity of the band intensities.
The resulting six bands were used for estimating the band
intensities per kilobase for each plasmid per experiment.
A Molecular-imager FX Pro (Bio-Rad) was used
for visualizing the bands and their densities were densito-
metorically estimated using ImageJ (http://rsb.info.nih.
gov/ij/).
RNA techniques
The total RNA was puriﬁed using the hot acid-phenol
method (13), and in the case of real-time quantitative
RT-PCR assays, the puriﬁed RNA was treated with
DNase I and further puriﬁed with the RNeasy Mini Kit
(Qiagen, Inc., Valencia, CA) to remove the genomic DNA
completely.
For northern blot analysis, typically 20mg of the total
RNA was loaded in each lane, and ribosomal RNA bands
were visualized by ethidium bromide staining and scanned
by the Molecular-imager FX Pro. Two 50-end-biotin-
labelled oligonucleotides (GGAAACAGCTATGACCAT
GATTACGGATTCACTGGCCGTCGTTTTACA and
GGTTATTTATGACTCAACAGCCACAAGCCAAAT
ACCGTCACGATTATC) were synthesized and used
as probes for lacZ and pepN PTasRNAs respectively; the
probes were detected on the membranes by streptavidin-
Alexa Fluor 680 conjugate (Invitrogen Corp.) and Odyssey
infrared-imaging system (LI-COR Biosciences, Lincoln,
NE) according to the manufacturer’s instructions.
A real-time quantitative RT-PCR assay was performed
using the One Step SYBR PrimeScript RT-PCR Kit II
(Takara Bio Co., Japan) and the Mx3000P Real-Time
PCR System. Results were analyzed with MxPro-Mx
3000P software (Stratagene). As a normalizer gene, 16S
rRNA was ampliﬁed with primers (TTGCTCATTGAC
GTTACCCG, ACGCCCAGTAATTCCGATTA) (14),
and the lacZ mRNA was ampliﬁed with primers (GAG
AATCCGACGGGTTGTTA, GTTGCACCACAGATG
AAACG) that were designed not to amplify the lacZ
PTasRNA.
Estimation of mutation frequency
Transformants with PTasRNA expression vector(s) were
pre-grown overnight in the absence of IPTG, diluted
1:2 10
7 with fresh media containing or not containing
1mM IPTG, and grown overnight. Appropriately diluted
cultures were plated onto LB, LB plus 100mgm l
 1 rifam-
picin, and LB plus 40mgm l
 1 nalidixic acid plates, and the
colonies that appeared after 15–18h of incubation were
counted. For one experiment of each transformant, six
replicates were analyzed and the median was obtained.
It is reported elsewhere that the median is more appro-
priate than the mean in this experiment (known as the
Luria–Delbru ¨ ck experiment or the ﬂuctuation test),
because the results are sensitive to occasional ‘‘jackpot’’
cultures; the median is not aﬀected by extreme scores (15).
For each transformant, mean of medians from sets of
three experiments was calculated.
RESULTS
Construction of PTasRNA expression vectors
We constructed four types of PTasRNA expressing vec-
tors as shown in Figure 1A and Table 1. All the vectors
harbored the trc promoter (Ptrc), lac operator sequence
(lac
o) and lac repressor gene (lacI
q); hence, PTasRNA
expression was IPTG inducible. Throughout the study,
asRNAs containing PT composed of 38 base pairs
(Figure 1B) were employed because such PT are known
to have the best silencing eﬃcacy (4). Each asRNA
sequence comprises of 101–152 nucleotides (Table 2),
was placed between the NcoI and XhoI restriction sites,
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mRNA.
pHN1009, pHN678, pHN1257 and pHN1270
(Figure 1A) were co-transformable and could be stably
maintained in a single cell in any combination because
each harbored a diﬀerent antibiotic resistance marker
and plasmid replication origin (ori). pHN1242
(Figure 1A) is identical to pHN1257, except that the
former harbors the pSC101 ori, which is the wild-type
ori of pSC101. The pSC101
H ori has a single-nucleotide
substitution in the pSC101 ori, and this substitution is
known to elevate the plasmid copy number to  4-fold
(16). The largest diﬀerence among these vectors is the
plasmid copy number, which is attributable to the ori,
and the reported copy number of each ori per cell is as
follows: pBR322, 50–70 (17); pACYC, 20–30 (17);
pSC101, 6–12 (16,17); pSC101
H, 30 (16) and RK2,
6–10 (18).
Single-gene silencing and effect of copy number
Before studying multiple-gene silencing, we ﬁrst validated
the abovementioned vectors by single-gene silencing.
We subcloned the lacZ asRNA sequence (Figure 2A)
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Figure 1. PTasRNA expression vectors and expressed PTasRNA. (A) Arrows indicate open reading frames or promoters, and circles indicate oris.
MCS, multiple cloning site; Amp
r, ampicillin-resistance gene; Chl
r, chloramphenicol-resistance gene; Kan
r, kanamycin-resistance gene and Apr
r,
apramycin-resistance gene. (B) Structure of a PTasRNA from its 50-end. The curved line indicates the asRNA sequence (or a MCS control sequence
in the case of an empty vector). The residues that have been underlined are transcribed from the lac8 sequence.
Table 1. Plasmids used
Plasmid name Relevant characteristics Source
(General cloning vector)
pACYC184 pACYC ori, Chl
r, Tet
r (45)
(Empty vector)
pHN1009 pBR322 ori, Amp
r, lacI
q,P trc, lac
o-PT-MCS This study
pHN678 pACYC ori, Chl
r, lacI
q,P trc, lac
o-PT-MCS (4)
pHN1242 pSC101 ori, Kan
r, lacI
q,P trc, lac
o-PT-MCS This study
pHN1257 pSC101
H ori, Kan
r, lacI
q,P trc, lac
o-PT-MCS This study
pHN1270 RK2 ori, Apr
r, lacI
q,P trc, lac
o-PT-MCS This study
(PTasRNA expression vector)
pHN1244 PBR322 ori, Amp
r, lacI
q,P trc, lac
o-PT-lacZ asRNA This study
pHN1246 pACYC ori, Chl
r, lacI
q,P trc, lac
o-PT-lacZ asRNA This study
pHN1249 PSC101 ori, Kan
r, lacI
q,P trc, lac
o-PT-lacZ asRNA This study
pHN1259 PSC101
H ori, Kan
r, lacI
q,P trc, lac
o-PT-lacZ asRNA This study
pHN1274 RK2 ori, Apr
r, lacI
q,P trc, lac
o-PT-lacZ asRNA This study
pHN1258 pACYC ori, Chl
r, lacI
q,P trc, lac
o-PT-pepN asRNA This study
pHN1275 RK2 ori, Apr
r,lacI
q,P trc, lac
o-PT-pepN asRNA This study
pHN1245 PBR322 ori, Amp
r, lacI
q,P trc, lac
o-PT-ackA asRNA This study
pHN1260 pSC101
H ori, Kan
r, lacI
q,P trc, lac
o-PT-pta asRNA This study
pHN1251 pACYC ori, Chl
r, lacI
q,P trc, lac
o-PT-mutS asRNA This study
pHN1295 PSC101
H ori, Kan
r, lacI
q,P trc, lac
o-PT-mutD asRNA This study
pHN1300 RK2 ori, Apr
r, lacI
q,P trc, lac
o-PT-ndk asRNA This study
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the presence of IPTG. As controls, transformants with
empty vectors were also used, and the silencing level
of each lacZ-PTasRNA-expressing vector was evaluated
relative to the LacZ activity of the corresponding empty
vector (Figure 2B). We chose this comparison method
because LacZ activities were diﬀerent among transfor-
mants with empty vectors, possibly due to diﬀerent lacI
q
gene dosage or the eﬀect of used antibiotics.
When the pBR322- or pSC101
H-ori-based vector (high-
copy vector) was used, over 85% of LacZ activity was lost.
On the other hand, when the pACYC-, pSC101- or
RK2-ori-based vector (medium- or low-copy vector) was
used, 62–76% of LacZ activity was lost. We experimen-
tally conﬁrmed the plasmid copy number of the vectors
(Table 3) and observed that these values were consistent
with the ones reported earlier except for the pSC101
H-ori-
based vector; the observed value was higher than expected.
Although the copy number of the RK2-ori-based vector
was almost the same as that of the pSC101-ori-based
vector (Table 3), the silencing level was diﬀerent between
these vectors (Figure 2B). In addition, a similar vector
dependent silencing pattern was observed when a gene
other than lacZ was targeted (see Supplementary
Figure S2). To further validate the vectors, we detected
the lacZ mRNA and the lacZ PTasRNA with real-time
quantitative RT–PCR and northern blot analyses, respec-
tively (Figure 2C and D). As expected, in general, when
the high-copy vectors were used, higher amounts of the
lacZ PTasRNA were expressed and lower lacZ mRNAs
remained. Also, the remaining LacZ activities (Figure 2B)
and the lacZ mRNAs (Figure 2C) were well-correlated,
but in the case of pSC101
H-ori-based vector, the lacZ
mRNA level was slightly high compared to the LacZ
level. From these results, we conclude that the plasmid
copy number greatly inﬂuences expression of PTasRNAs
and silencing eﬃcacy, but also other factors such as plas-
mid stability and/or overall plasmid structure are
important.
Growth rates of all the transformants, including
the control transformant, in the presence of IPTG were
indistinguishable (data not shown), indicating that the
expression of the lacZ PTasRNA has no oﬀ-target eﬀect
on other genes crucial for growth.
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Figure 2. Silencing of lacZ with PTasRNAs. (A) Schematic maps of the lacZ mRNA and the lacZ asRNA sequence. (B) Cells were transformed with
ﬁve lacZ-PTasRNA-expressing vectors (pHN1244, pHN1246, pHN1249, pHN1259 and pHN1274) and ﬁve empty vectors (pHN1009, pHN678,
pHN1242, pHN1257 and pHN1270) and cultured in the presence of IPTG. Each LacZ activity remaining was calculated as; LacZ activity of a
transformant with a lacZ-PTasRNA-expressing vector (Units)/LacZ activity of a transformant with a corresponding empty vector (Units). Absolute
LacZ activities of all transformants are shown in Figure S1. The values are represented as the mean   standard deviation (SD) of three replicates.
(C) The lacZ mRNAs remaining after silencing were quantiﬁed with real-time quantitative RT-PCR. Each value was calculated in the same way as in
the panel (B). (D) The lacZ PTasRNA was detected by northern blot (lower panel). The rRNA bands stained with ethidium bromide (upper panel)
were used as loading controls. As the no lacZ asRNA control, the transformant with pACYC184 was used.
Table 2. Oligonucleotides used for asRNA ampliﬁcation
Target
gene
Sequence Length of
asRNA
sequence (bp)
lacZ gcactcgaggctttacactttatgcttcc 119
tcccatggttgtaaaacgacggccagtgaatc
pepN cgctcgaggaatagactgaacaccagactc 102
taccatggtaatccggcgcacgataatcg
ackA aactcgagctacgctctatggctccctgac 147
caccatggtactcttcaccatttactgcatc
pta ccctcgaggcggtaacgaaagaggataaac 101
ttccatggcacggatcacgccaaggctg
mutS aactcgagccatcacaccccatttaatatcagg 110
ggccatgggctttcagcctgagatactgct
mutD tgctcgagcatctctggtagacttcctgta 152
tcccatggccttcatagtgcgcaccaatc
ndk ccctcgagctcattataatccgcgccatct 115
gtccatggctaccgcgttcggtttgatgat
Table 3. Plasmid copy number
ori pBR322 pACYC pSC101 pSC101
H RK2
Relative
copy no.
a
2.5 0.3 1.1 0.2 0.56 0.04 2.0 0.1 0.59 0.05
aPlasmid copy number per cell relative to that of pACYC184, and
averaged values from triplicate experiments are shown with SD.
Plasmid names used are (from left to right) pHN1244, pHN1246,
pHN1249, pHN1259 and pHN1274.
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reporter gene, pepN (encoding an aminopeptidase) (19),
was targeted in the same way as lacZ was (Figure 3A),
and 90 and 88% of the PepN activity was reduced, respec-
tively (Figure 3B). Therefore, the RK2-ori-based vector
exerts suﬃcient silencing eﬃcacy when the target gene is
susceptible to PTasRNA. However, when transformants
harboring the pepN-PTasRNA-expressing vector were cul-
tured without IPTG as controls, signiﬁcant reduction of
PepN activity was observed (30–60%, Figure 3B). When
other genes were targeted, no or little silencing was
observed in the absence of IPTG (4) (also see below).
These results indicate that in the absence of IPTG, the
basal expression level of Ptrc aﬀects the expression of
target genes only when they are PTasRNA-sensitive.
There are many reports indicating that expression from
Ptrc is leaky (20), and we experimentally conﬁrmed signif-
icant expression of the pepN PTasRNA in the absence
of IPTG (Figure 3C). If basal expression from Ptrc is pro-
blematic, the promoter should be changed to tightly-
regulated ones. For example, we have reported a
PTasRNA-expressing vector from which expression is
induced with L-arabinose and is less leaky (pHN649, see
Supplementary Figure S3) (4). Indeed, when pepN was
targeted using this vector, reduction of PepN activity
was observed only in the presence of L-arabinose (see
Supplementary Figure S3).
The growth rates of all these transformants in the pres-
ence of IPTG were indistinguishable (data not shown),
again indicating that no critical oﬀ-target genes were
aﬀected.
Double silencing within an operon
To experimentally conﬁrm multiple-gene silencing, the
ackA-pta operon was chosen as the next target of
PTasRNAs (Figure 4A) because the enzymatic activities
of AckA and Pta can be easily measured. The ackA and
pta genes encode acetate kinase and phosphotransacety-
lase respectively, and both are involved in acetate metab-
olism (21). The ackA PTasRNA was expressed from the
pBR322-ori-based vector, and the pta PTasRNA was
expressed from the pSC101
H-ori-based vector. Silencing
eﬃcacy was determined using single-transformants
of each PTasRNA-expressing vector and using co-
transformants of both the vectors. The result (Figure 4B
and C) indicated that double silencing is possible by
co-transformation, and the level of silencing of both the
genes in the co-transformant was the same or higher than
that in each single-transformant.
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to those of corresponding disruptants (schematic maps of
the disruptants are shown in Figure S4). Cells expressing
the ackA PTasRNA grew slower than wild-type cells but
faster than DackA cells (Figure 5A). Cells expressing the
pta PTasRNA grew similarly to wild-type cells, while Dpta
cells grew slowly but to high cell densities compared to
wild-type cells (Figure 5B). Similar growth phenotypes of
pta mutants have been reported by other groups (22,23).
Cells expressing both the ackA and pta PTasRNAs grew
poorly, but DackA Dpta cells grew to high cell densities as
Dpta cells (Figure 5C). We assume that these discrepancies
in the growth rates are unrelated to oﬀ-target eﬀects of
the PTasRNAs because growth retardation caused by
expressing ackA and pta PTasRNAs was recovered
by overexpressing the ackA and pta genes (Figure S5).
Instead, residual AckA and/or Pta activities in
PTasRNA-expressing cells might aﬀect the growth rate,
or because AckA activity in Dpta cells and Pta activity
in DackA cells were reduced to 69 and 62% respectively
(see Supplementary Figure S4), imbalance between AckA
and Pta in the disruptants might have impact on the
growth rates.
Quadruple silencing
Next, we wanted to determine whether the simultaneous
co-transformation with the four vectors and quadruple
silencing are possible. The lacZ, pepN, ackA and pta
PTasRNAs were expressed from the pACYC-, RK2-,
pBR322- and pSC101
H-ori-based vectors, respectively.
Silencing eﬃcacy in a quadruple transformant of these
vectors was evaluated by measuring LacZ, PepN, AckA
and Pta activities, and the activities were compared to
those of a control transformant with four empty vectors
(Figure 6). We conﬁrmed that all the genes were silenced,
and the silencing eﬃcacies were comparable to those of
their respective single transformants (Figures 2B, 3B, 4B
and 4C). From these results, we conclude that simultane-
ous silencing of up to four genes is possible.
Application of the multiple-gene silencing system
A multiple-gene silencing method will enable the investi-
gation of the functional relationships among genes. In
order to determine the functional relationship among
related genes, we selected the mutator genes mutS, mutD
(dnaQ) and ndk as targets of the PTasRNA. The mutS
gene product is involved in DNA mismatch repair
(24,25), mutD encodes DNA polymerase e subunit (30–50
exonuclease) (26–28), and ndk encodes nucleotide dipho-
sphate kinase (Ndk) (29). The Ndk protein is involved in
the maintenance of deoxyribonucleotide triphosphate
(dNTP) pools, and an ndk-deﬁcient strain has an imbal-
anced dNTP pool (29). E. coli strains with defects in any
of these genes tend to have elevated spontaneous mutation
frequency (30).
The mutS, mutD and ndk asRNA sequences were sub-
cloned into the pACYC-, pSC101
H- and RK2-ori-based
vectors, respectively, and the PTasRNAs were expressed
in various combinations (Figure 7). When any of the
PTasRNAs directed against these genes was expressed,
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quency, which was determined by the rate of appearance
of rifampicin- (Rif
r) and nalidixic acid (Nal
r)-resistant
colonies (Figure 7). The mutation frequency increased
with the number of silenced genes; the highest frequency
was observed when three genes were silenced, and it was
over 2000-fold higher than that of the control. The eﬀect
of the ndk PTasRNA was observed to a limited extent
compared to that of the mutS or mutD PTasRNA. This
ﬁnding is consistent with the results of the previous study
which indicated that ndk is a modest base substitution
mutator and its phenotype is strengthened in the mutS
background (29). Taken together, the results suggest
that silencing of multiple mutator genes causes additive
or synergistic increase of spontaneous mutation fre-
quency, thereby generating a mutator strain.
Till date, many mutator genes have been identiﬁed
(30), and therefore further silencing of fourth gene is pos-
sible. However, we think that this mutator strain can
be used for preparing plasmid libraries that harbor
random mutations (see ‘Discussion’ section for details).
Given that most popular cloning vectors have pBR322
ori (or closely related pUC ori) and the ampicillin-
resistance gene, we think that it is better to avoid using
the pBR322-ori-based vector (pHN1009, Figure 1) for
silencing of mutator genes.
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The advantages of the gene-silencing method used in this
study are inducibility, portability, high throughput and
multiplicity of the targeted genes. The inducibility and
portability enable the application of this method to
genes essential for growth and to any E. coli strain. The
high throughput and multiplicity are important features
for genome-wide analyses, systems biology or gene-
network analyses. It is noteworthy that this is one of the
ﬁrst examples of multiple-gene silencing in bacteria. In this
study, we showed simultaneous gene silencing of up to
four genes; however, we assume that there is requirement
for silencing more genes simultaneously. The easiest solu-
tion for this is to sub-clone multiple asRNA sequences
into one vector. Alternatively, it should also be possible
to integrate PTasRNA expression cassettes into chro-
mosomes by using transposons or site-directed recombi-
nation methods, although in this case, the portability of
PTasRNAs is lost. Another possibility is to add synthetic
antisense agents (antisense oligonucleotides or such ana-
logues) into the culture media (31); however, this method
is costly and is not applicable in the case of large-scale
cultures. Taken together, it seems that the most feasible
strategy is to develop gene-silencing methods that can
complement those available for gene knock-out. It
should also be noted that several methods have been
developed for achieving homologous recombination and
gene disruption without leaving transformation markers
on chromosomes (32,33).
Expressed asRNAs have been shown to function
in diverse bacteria, and thus far, the asRNAs developed
in bacteria are mostly targeted against the RBS and start-
codon region (3). This suggests that asRNAs inhibit gene
expression by steric hindrance of ribosomes (3). However,
in general, the methods for developing asRNAs in bacteria
are more diﬃcult than those for developing asRNAs in
eukaryotes. This is thought to be due to the coupling of
transcription and translation processes in bacteria.
Bacterial ribosomes can initiate translation even when
nascent mRNAs are being transcribed because bacteria
do not have a nuclear membrane that sequesters ribo-
somes from the transcription machineries (2).
Consequently, there is little time for bacterial asRNAs
to access target mRNAs, and indeed, it has been reported
that the eﬃcacy of asRNAs increases when translation is
decoupled from transcription using mutant ribosomes
with slow translation rates (2). In order to overcome this
coupling problem in wild-type cells, bacterial asRNAs
usually have to be in excess quantities compared to that
of the target mRNAs (2,4). Our PTasRNA design pro-
vides one advantage: the PT portion stabilizes asRNAs,
thus resulting in higher accumulation of PTasRNAs (4).
Increasing the plasmid copy number is another option that
has been shown in Figure 2.
As shown in Figures 2B and 3B, the sensitivity of target
mRNAs to PTasRNA silencing varies. We assume that
the sensitivity is determined by many factors such as
mRNA turnover rate, steady-state mRNA expression
level, eﬀectiveness of the mRNA translation initiation
and accessibility of the PTasRNA to the mRNA.
Among these factors, accessibility appears to be very
important on the basis of the following observation:
when lacZ was targeted by several versions of lacZ
PTasRNAs, which were of similar length and carried the
anti-RBS sequences but were targeted at slightly diﬀerent
positions of the lacZ mRNA, the silencing eﬃcacy clearly
diﬀered among the diﬀerent versions (see Supplementary
Figure S6). Probably, the mRNA secondary structure
aﬀects the accessibility of PTasRNAs. However, there
could be other possible reasons, and further studies need
to be performed for comparing the eﬃcacy of the diﬀerent
versions, and the use of tools for predicting target-site
accessibility (34) may be helpful.
Recently, it has been shown that many bacteria have
natural small RNAs that act as asRNAs and inhibit func-
tion of speciﬁc mRNAs (35,36). Stability and function of
such RNAs are frequently governed by RNA chaperons,
e.g. Hfq (35,36). Exploiting such endogenous mechanisms
but not using the artiﬁcial PT design shown here is
an alternate choice for eﬃcient silencing. However,
it should be noted that over-expressed natural small
RNAs may compete endogenous mechanisms (e.g. com-
petes for Hfq binding) and may cause unwanted pheno-
types non-speciﬁcally.
Triple silencing of mutator genes and generation of a
mutator strain have been demonstrated in this study.
Mutator strains are useful for introducing random muta-
tions in plasmids. The most popular mutator strain is
E. coli XL1-Red (Stratagene), which has mutations in
mutS, mut, and mutT loci and has a 5000-fold higher
mutation frequency than the wild type (37,38).
Therefore, the XL1-Red strain is used to generate plasmid
libraries harboring random mutations. However, the
growth of the XL1-Red strain is very slow, and maintain-
ing it in a stable state is problematic. Our mutator strain is
more advantageous than the XL1-Red strain because the
mutation frequency can be adjusted by adding or remov-
ing the plasmid and maintenance is simple. Camps and co-
workers recently reported an alternative method to create
mutator strains. They employed a highly error-prone
DNA polymerase I coded on a plasmid (39). The most
advantageous feature of their method is that the muta-
tions occurring on plasmids is 400-fold higher than those
on chromosomes, thus ensuring genetic stability of the
host strain. It might be interesting to investigate the com-
bination of our method with theirs for introduction of
more mutations.
We believe that there are other possible applications
of this method because most cellular phenotypes are
governed by multiple genes; hence, obtaining a desired
phenotype often requires simultaneous manipulation of
multiple genes. For example, while producing industrially
valuable metabolic intermediates such as succinate, it is
necessary to disrupt or silence multiple genes involved in
central carbon ﬂux (40,41). The central carbon ﬂux is com-
posed of complex gene networks, and recent advances in
systems biology make it possible to predict the number of
genes that have to be disrupted or silenced for optimized
carbon ﬂux. Our method is appropriate for this purpose
because it has a higher throughput than gene disruption
method and many silencing combinations can be easily
PAGE 9 OF 11 Nucleic Acids Research, 2009,Vol.37, No. 15 e103tested. In addition, silencing of essential genes can lead to
the discovery of new antimicrobials, which are in great
demand (42,43), as demonstrated by the recent discovery
of platensimycin (44). Our genetic studies performed at
RNA level will assist researches in the identiﬁcation of
gene functions and cell engineering.
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